<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4287530</article-id>
    <article-id pub-id-type="pmid">25272949</article-id>
    <article-id pub-id-type="publisher-id">6647</article-id>
    <article-id pub-id-type="doi">10.1186/1471-2105-15-326</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Prediction of uridine modifications in tRNA sequences</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Panwar</surname>
          <given-names>Bharat</given-names>
        </name>
        <address>
          <email>bharat@imtech.res.in</email>
        </address>
        <xref ref-type="aff" rid="Aff22"/>
        <xref ref-type="aff" rid="Aff23"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Raghava</surname>
          <given-names>Gajendra PS</given-names>
        </name>
        <address>
          <email>raghava@imtech.res.in</email>
        </address>
        <xref ref-type="aff" rid="Aff22"/>
      </contrib>
      <aff id="Aff22"><label/>Bioinformatics Centre, CSIR-Institute of Microbial Technology, Sector 39A, Chandigarh, India </aff>
      <aff id="Aff23"><label/>Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109 USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>2</day>
      <month>10</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2014</year>
    </pub-date>
    <volume>15</volume>
    <issue>1</issue>
    <elocation-id>326</elocation-id>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>4</month>
        <year>2014</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>9</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© Panwar and Raghava; licensee BioMed Central Ltd. 2014</copyright-statement>
      <license license-type="open-access">
        <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p>In past number of methods have been developed for predicting post-translational modifications in proteins. In contrast, limited attempt has been made to understand post-transcriptional modifications. Recently it has been shown that tRNA modifications play direct role in the genome structure and codon usage. This study is an attempt to understand kingdom-wise tRNA modifications particularly uridine modifications (UMs), as majority of modifications are uridine-derived.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>A three-steps strategy has been applied to develop an efficient method for the prediction of UMs. In the first step, we developed a common prediction model for all the kingdoms using a dataset from MODOMICS-2008. Support Vector Machine (SVM) based prediction models were developed and evaluated by five-fold cross-validation technique. Different approaches were applied and found that a hybrid approach of binary and structural information achieved highest Area under the curve (AUC) of 0.936. In the second step, we used newly added tRNA sequences (as independent dataset) of MODOMICS-2012 for the kingdom-wise prediction performance evaluation of previously developed (in the first step) common model and achieved performances between the AUC of 0.910 to 0.949. In the third and last step, we used different datasets from MODOMICS-2012 for the kingdom-wise individual prediction models development and achieved performances between the AUC of 0.915 to 0.987.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>The hybrid approach is efficient not only to predict kingdom-wise modifications but also to classify them into two most prominent UMs: Pseudouridine (Y) and Dihydrouridine (D). A webserver called <italic>tRNAmod</italic> (<ext-link ext-link-type="uri" xlink:href="http://crdd.osdd.net/raghava/trnamod/">http://crdd.osdd.net/raghava/trnamod/</ext-link>) has been developed, which predicts UMs from both tRNA sequences and whole genome.</p>
      </sec>
      <sec>
        <title>Electronic supplementary material</title>
        <p>The online version of this article (doi:10.1186/1471-2105-15-326) contains supplementary material, which is available to authorized users.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Uridine modifications</kwd>
      <kwd>Pseudouridine</kwd>
      <kwd>Dihydrouridine</kwd>
      <kwd>5-methyl-uridine</kwd>
      <kwd>tRNAmod</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2014</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p>Post-transcriptional modification plays an imperative role in tRNA secondary and tertiary structure formation [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], stability [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR6">6</xref>] and ultimately affects tRNA functions [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Sometimes it leads to the alternative folding of tRNAs [<xref ref-type="bibr" rid="CR1">1</xref>]. It provides structural flexibility to tRNA and rigidifies certain regions to fine-tune the molecule for maximum performance [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. It affects the gene expressions [<xref ref-type="bibr" rid="CR10">10</xref>], translation speed and accuracy [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]; enhances the accuracy of codon binding [<xref ref-type="bibr" rid="CR13">13</xref>] and codon discrimination ability of tRNAs [<xref ref-type="bibr" rid="CR14">14</xref>]. Modification prevents frame shifting [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] that is required for the maintenance of proper translational reading frame [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] and enables translocation of the tRNA from A to P site [<xref ref-type="bibr" rid="CR18">18</xref>]. Some modified bases, particularly modifications of anticodon domain help in the amino-acylation reaction of aminoacyl-tRNA synthetases through recognition of cognate tRNAs [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. It is a principal reaction for the precise flow of genetic information into protein sequences [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].</p>
    <p>The position of modified base in tRNA sequence is also important because modified wobble position 34 expands tRNA ability to read more than one codons [<xref ref-type="bibr" rid="CR24">24</xref>]. It contributes 30-40% of all codon recognition depending on the codon usage of an organism [<xref ref-type="bibr" rid="CR8">8</xref>]. U<sub>34</sub> is mostly modified [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] and is responsible for the majority of wobble based codon recognitions [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. The tRNA modifications are involve in various diseases such as Type 2 diabetes [<xref ref-type="bibr" rid="CR29">29</xref>–<xref ref-type="bibr" rid="CR31">31</xref>], Cancer [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR35">35</xref>] and mitochondrial disease [<xref ref-type="bibr" rid="CR36">36</xref>]. Modification also plays important role in human immunodeficiency virus selection of a specific human tRNA to prime reverse transcription [<xref ref-type="bibr" rid="CR37">37</xref>]. A recent study showed that tRNA modifications play an important role in genome structure and codon usage [<xref ref-type="bibr" rid="CR38">38</xref>]. Yet, cellular and functional dynamics of tRNA modifications is unexplored and poorly understood due to the absence of large-scale analysis and quantification of modifications. The experimental determination of tRNA modification is also an expensive, tedious and labor-intensive process. Therefore, there is a need to develop an algorithm for the prediction of tRNA modifications.</p>
    <p>In this study, an attempt has been made to develop <italic>in-silico</italic> technique for identification of modified bases in tRNA sequence. We retrieved and analyzed modified tRNA from MODOMICS database [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>] and observed that most of the modifications are uridine-derived. Therefore, we focused our study on the prediction of uridine modifications (UMs) in tRNA. We used various features such as compositions, binary and structural information of tRNA for developing Support Vector Machines (SVMs) based models for identification of modified uridine in tRNA. It was observed that Pseudouridine (Y) and Dihydrouridine (D) were more prevalent modifications in the tRNA sequences. Therefore separate prediction models have been developed for these (D and Y) prominent uridine modifications (UMs). It is known that modification varies between different kingdoms; therefore we also developed kingdom-specific prediction models. This sequence based prediction and classification of UMs will help the scientific community to explore tRNA biology. In this era of Next-Generation Sequencing (NGS), tRNAmod tool developed in this study will be useful for the genome-wide prediction of tRNA modifications.</p>
  </sec>
  <sec id="Sec2" sec-type="results">
    <title>Results</title>
    <p>In this study, two different version of MODOMICS database update 2008 [<xref ref-type="bibr" rid="CR39">39</xref>] and update 2012 [<xref ref-type="bibr" rid="CR40">40</xref>] have been used. Update 2008 and 2012 of MODOMICS database were containing 218 and 642 tRNA (modified) sequences respectively. In the analysis part, we used all the 642 tRNAs of the 2012 update. We analyzed position-specific base conservation in standard 1–99 (or 0–98) representation using WebLogo [<xref ref-type="bibr" rid="CR41">41</xref>] and observed that some positions were conserved whereas most of positions have variants (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). Thus, determination of position-specific modification in the variable region is a major challenge.</p>
    <sec id="Sec3">
      <title>Analysis of all tRNA modifications</title>
      <p>We observed that ~13% bases were modified. It means that on an average, 10 bases of each tRNA (average 77 nucleotides long) were modified. The nucleotide-compositions of U, G, A, C and any/other in tRNA sequences were 24.31%, 27.62%, 22.5%, 25.34% and 0.22% respectively. The U-, G-, A- and C-derived modifications were 55.85%, 19.71%, 12.28% and 10.41% of all tRNA modifications respectively. Base specific modification rate varies between the different kingdoms but still uridine-derived modifications are most abundant in all the kingdoms (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2). The 29.27% of all uridines were modified whereas only 9.09% of guanines, 6.94% of adenines and 5.21% of cytosines were modified. We observed in the kingdom-wise Two Sample Logos (TSLs) of modified and unmodified patterns (sliding windows of 15 lengths) that uridines were also most abundant in the neighboring positions of modified base whereas cytosines and guanines were preferred in the neighboring positions of unmodified bases (Figure <xref rid="Fig1" ref-type="fig">1</xref>). Most of modifications were uridine-derived; therefore we selected only these modifications for further study.<fig id="Fig1"><label>Figure 1</label><caption><p><bold>Kingdom-wise Two-Sample Logos of all modified and unmodified bases using 15-length sliding window patterns.</bold> All bases of central position (8th) are modified and unmodified for positive and negative samples respectively.</p></caption><graphic xlink:href="12859_2014_6647_Fig1_HTML" id="d30e415"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Analysis of uridine modifications (UMs)</title>
      <p>There are several modifying enzymes that play important role in the post-transcriptional modifications of tRNA. It is important to investigate the differences between modified (29.27%) and unmodified uridines. Therefore, we created kingdom-wise TSLs and observed that significant differences were present between modified and unmodified uridines (Figure <xref rid="Fig2" ref-type="fig">2</xref>). The bases of central (8th) position were modified/unmodified uridines. The modified uridines were flanked by guanine (5′ end) and uridine (both 5′ and 3′ end) whereas unmodified uridines preferred cytosine (5′ end) and guanine (3′ end) as neighbors. Most of modified uridines preferred guanine at 6th and adenine at 11-12th positions (Figure <xref rid="Fig2" ref-type="fig">2</xref>). Although, there were 22 different type of uridine-modifications present but Pseudouridine (Y) was most (~45% of all UMs) abundant UMs (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Sequence-based conservation of pseudouridine modifications was analyzed and observed that there was very low conservation present (Figure <xref rid="Fig3" ref-type="fig">3</xref>). Only some conservation of uridine at 5′ and cytosine at 3′end was present (especially in bacteria). It is well known because TYC (UUC in the WebLogo) is always present in TSL but pseudouridine is also present at other sites. The Dihydrouridine (D) was second most abundant (~32% of all UMs) and only present in the DSL but as WebLogos suggested that there was no sequence-based conservation present for this modification (Figure <xref rid="Fig3" ref-type="fig">3</xref>). On the basis of these analyses, we developed prediction models for the all uridine-modification, pseudouridine and dihydrouridine separately.<fig id="Fig2"><label>Figure 2</label><caption><p><bold>Kingdom-wise Two-Sample Logos of modified and unmodified uridines using 15-length sliding window patterns (central 8th position for modified/unmodified uridines).</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig2_HTML" id="d30e448"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p><bold>Kingdom-wise WebLogos of pseudouridine and dihydrouridine using 15-length sliding window patterns (central 8th position for pseudouridine/dihydrouridine).</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig3_HTML" id="d30e460"/></fig></p>
      <p>In this study, we used a three-step strategy to develop an efficient method for the prediction and classification of uridine modifications. In first step, we developed a common prediction method using tRNA-136 dataset of MODOMICS database update 2008 [<xref ref-type="bibr" rid="CR39">39</xref>]. In the second step, we used newly added tRNA sequences (as independent dataset) of MODOMICS database update 2012 [<xref ref-type="bibr" rid="CR40">40</xref>] for the kingdom-wise prediction performance evaluation of previously developed (in first step) common model. In the last step, we used tRNA-419 and tRNA-471 datasets (See details in the Methods section) of MODOMICS database update 2012 for the kingdom-wise prediction model development.</p>
    </sec>
    <sec id="Sec5">
      <title>Identification of uridine modifications</title>
      <p>In past, various machine learning based prediction methods have been developed for biological problems and SVM is one of the most powerful and highly used algorithms. First, we generated sliding window of different lengths and created positive and negative patterns. If central nucleotide of window is modified uridine, the whole pattern was used as positive otherwise windows with unmodified uridines at central positions were used as negative patterns (see material and methods section). We optimized window sizes by prediction performances and applied following approaches and developed various SVM-based prediction models. In first step, all models were developed on a non-redundant dataset called ‘tRNA-136’ (see Methods section), which contain 136 tRNA sequences, where no two sequences have more than 50% sequence similarity.</p>
      <sec id="Sec6">
        <title>Compositions-based approaches</title>
        <p>We developed various SVM based modules for predicting modified uridine in tRNA using mono-, di- and tri-nucleotide composition (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S3-S5) and optimized window size for achieving best performance in terms of area under curve (AUC). We achieved maximum AUC 0.76, 0.84 and 0.865 for mono-, di- and tri-nucleotide composition respectively.</p>
      </sec>
      <sec id="Sec7">
        <title>Binary approach</title>
        <p>The compositions-based approaches give information of only nucleotide frequencies; it has no information about sequential arrangement of these nucleotides. Therefore, we applied binary approach, which is widely used and is a successful strategy for the nucleotide (or residue) level predictions [<xref ref-type="bibr" rid="CR42">42</xref>]. First, we generated binary profiles of patterns (BPP) of length 3 to 25 nucleotides. These BPPs were used to develop SVM based methods for predicting modified uridine in tRNA sequences. We computed performance of window length 3 to 25 and achieved maximum MCC 0.72 with accuracy 89.13% and AUC 0.924 at 17-window length (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6).</p>
      </sec>
      <sec id="Sec8">
        <title>Structure-based approaches</title>
        <p>All nucleotide sequences of tRNAs fold into well-defined cloverleaf like structures. There are loop-specific UMs presents in D-stem loop (DSL), T-stem loop (TSL), Anticodon-stem loop (ASL) and Variable loop (VL). Therefore, this structural information can also be useful for the prediction of UMs. We used three different software packages namely RNAfold [<xref ref-type="bibr" rid="CR43">43</xref>], IPknot [<xref ref-type="bibr" rid="CR44">44</xref>] and tRNAscan-SE [<xref ref-type="bibr" rid="CR45">45</xref>] for predicting structure of tRNA. The binary representation of predicted tRNA structure was used for developing SVM based models (see material and methods section). The performance of SVM models were based on the binary representation of structures tRNA, predicted using RNAfold, IPknot and tRNAscan-SE shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S7, S8 and S9 respectively. At window length 19, we achieved MCC 0.73 with AUC 0.925 for models based on predicted structures using tRNAscan-SE. One possible reason of better performance of tRNAscan-SE approach is that it was developed specifically for tRNA and it predicted DSL, ASL, VL and TSL boundaries correctly in comparison to RNAfold and IPknot.</p>
      </sec>
      <sec id="Sec9">
        <title>Hybrid approach</title>
        <p>As shown in above sections, SVM models based on BPP (window length 17) and on tRNAscan-SE (window length 19) predicted structures performed better than other models. In order to improve performance of our approach, we developed a model using windows-based five-fold cross validation that combines both types of information (see Methods section). This hybrid model performs better than existing models and achieved maximum 85.92% sensitivity, 91.68% specificity, 90.14% accuracy, MCC 0.76 and AUC of 0.936 (Figure <xref rid="Fig4" ref-type="fig">4</xref>a). We also used sequence-based five-fold cross validation of tRNA-136 dataset, where we kept all the windows of any single tRNA into a same sub-set during five-fold cross validation and achieved almost equal performance (83.13% Sensitivity, 92.36% Specificity, 89.84% accuracy and 0.75 MCC) to the window-based five-fold cross validation.<fig id="Fig4"><label>Figure 4</label><caption><p><bold>ROC plots showing prediction performances of (a) all uridine, (b) pseudouridine and (c) dihydrouridine modifications using Binary, tRNAscan-SE and Hybrid approaches on the tRNA-136 dataset.</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig4_HTML" id="d30e529"/></fig></p>
        <p>To check whether over-representation of Pseudouridine (Y), Dihydrouridine (D) and 5-methyl-uridine (T) caused any SVM paramer over-fitting or not, we have used almost equal representation of different modifications. We randomly selected 30 Y, 30 D, 30 T and 92 all other uridine modifications from the tRNA-136 dataset for model development. On this randomized dataset, we have achieved 85.72% sensitivity, 97.34% specificity, 96.27% accuracy, MCC 0.79 and AUC of 0.974 on the same previosuly optimized parameter (−z c -t 2 -g 0.05 -c 2 -j 2). It means there is no SVM parameter overfitiing during model development (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p><bold>SVM performance on the complete tRNA-136 and randomly selected tRNA-136 dataset using the same parameter (-z c -t 2 -g 0.05 -c 2 -j 2)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Threshold</th><th colspan="4">Complete tRNA-136 dataset</th><th colspan="4">Randomized tRNA-136 dataset</th></tr><tr><th>SN</th><th>SP</th><th>ACC</th><th>MCC</th><th>SN</th><th>SP</th><th>ACC</th><th>MCC</th></tr></thead><tbody><tr><td><bold>−1.00</bold></td><td align="center">96.37</td><td align="center">60.89</td><td align="center">70.42</td><td align="center">0.51</td><td align="center">97.24</td><td align="center">78.59</td><td align="center">80.30</td><td align="center">0.49</td></tr><tr><td><bold>−0.90</bold></td><td align="center">95.31</td><td align="center">70.16</td><td align="center">76.91</td><td align="center">0.58</td><td align="center">96.68</td><td align="center">85.80</td><td align="center">86.80</td><td align="center">0.58</td></tr><tr><td><bold>−0.80</bold></td><td align="center">94.25</td><td align="center">76.37</td><td align="center">81.17</td><td align="center">0.63</td><td align="center">96.13</td><td align="center">90.13</td><td align="center">90.68</td><td align="center">0.65</td></tr><tr><td><bold>−0.70</bold></td><td align="center">93.64</td><td align="center">80.42</td><td align="center">83.97</td><td align="center">0.67</td><td align="center"><bold><italic>93.36</italic></bold></td><td align="center"><bold><italic>92.96</italic></bold></td><td align="center"><bold><italic>93.00</italic></bold></td><td align="center"><bold><italic>0.70</italic></bold></td></tr><tr><td><bold>−0.60</bold></td><td align="center">92.13</td><td align="center">83.30</td><td align="center">85.67</td><td align="center">0.69</td><td align="center">91.71</td><td align="center">94.56</td><td align="center">94.31</td><td align="center">0.73</td></tr><tr><td><bold>−0.50</bold></td><td align="center">91.37</td><td align="center">85.14</td><td align="center">86.81</td><td align="center">0.71</td><td align="center">89.52</td><td align="center">95.73</td><td align="center">95.16</td><td align="center">0.76</td></tr><tr><td><bold>−0.40</bold></td><td align="center">90.31</td><td align="center">86.63</td><td align="center">87.62</td><td align="center">0.72</td><td align="center">88.44</td><td align="center">96.51</td><td align="center">95.77</td><td align="center">0.78</td></tr><tr><td><bold>−0.30</bold></td><td align="center">89.40</td><td align="center">87.80</td><td align="center">88.23</td><td align="center">0.73</td><td align="center">87.34</td><td align="center">96.89</td><td align="center">96.02</td><td align="center">0.78</td></tr><tr><td><bold>−0.20</bold></td><td align="center"><bold><italic>88.64</italic></bold></td><td align="center"><bold><italic>89.35</italic></bold></td><td align="center"><bold><italic>89.17</italic></bold></td><td align="center"><bold><italic>0.75</italic></bold></td><td align="center"><bold>85.72</bold></td><td align="center"><bold>97.34</bold></td><td align="center"><bold>96.27</bold></td><td align="center"><bold>0.79</bold></td></tr><tr><td><bold>−0.10</bold></td><td align="center">87.43</td><td align="center">90.57</td><td align="center">89.73</td><td align="center">0.75</td><td align="center">84.07</td><td align="center">97.67</td><td align="center">96.42</td><td align="center">0.79</td></tr><tr><td><bold>0.00</bold></td><td align="center"><bold>85.92</bold></td><td align="center"><bold>91.68</bold></td><td align="center"><bold>90.14</bold></td><td align="center"><bold>0.76</bold></td><td align="center">80.80</td><td align="center">98.17</td><td align="center">96.58</td><td align="center">0.79</td></tr><tr><td><bold>0.10</bold></td><td align="center">83.80</td><td align="center">92.57</td><td align="center">90.22</td><td align="center">0.75</td><td align="center">75.82</td><td align="center">98.56</td><td align="center">96.47</td><td align="center">0.78</td></tr><tr><td><bold>0.20</bold></td><td align="center">81.08</td><td align="center">93.01</td><td align="center">89.81</td><td align="center">0.74</td><td align="center">74.71</td><td align="center">98.78</td><td align="center">96.58</td><td align="center">0.78</td></tr><tr><td><bold>0.30</bold></td><td align="center">79.72</td><td align="center">93.62</td><td align="center">89.90</td><td align="center">0.74</td><td align="center">71.44</td><td align="center">98.89</td><td align="center">96.37</td><td align="center">0.77</td></tr><tr><td><bold>0.40</bold></td><td align="center">76.70</td><td align="center">94.34</td><td align="center">89.61</td><td align="center">0.73</td><td align="center">68.69</td><td align="center">99.00</td><td align="center">96.22</td><td align="center">0.76</td></tr><tr><td><bold>0.50</bold></td><td align="center">73.67</td><td align="center">95.28</td><td align="center">89.49</td><td align="center">0.72</td><td align="center">62.69</td><td align="center">99.11</td><td align="center">95.77</td><td align="center">0.72</td></tr><tr><td><bold>0.60</bold></td><td align="center">69.43</td><td align="center">95.89</td><td align="center">88.80</td><td align="center">0.70</td><td align="center">58.27</td><td align="center">99.33</td><td align="center">95.57</td><td align="center">0.70</td></tr><tr><td><bold>0.70</bold></td><td align="center">65.20</td><td align="center">96.67</td><td align="center">88.23</td><td align="center">0.69</td><td align="center">53.87</td><td align="center">99.33</td><td align="center">95.16</td><td align="center">0.67</td></tr><tr><td><bold>0.80</bold></td><td align="center">59.00</td><td align="center">97.28</td><td align="center">87.01</td><td align="center">0.65</td><td align="center">45.11</td><td align="center">99.39</td><td align="center">94.41</td><td align="center">0.61</td></tr><tr><td><bold>0.90</bold></td><td align="center"><italic>51.59</italic></td><td align="center"><italic>97.78</italic></td><td align="center"><italic>85.39</italic></td><td align="center"><italic>0.60</italic></td><td align="center">32.40</td><td align="center">99.45</td><td align="center">93.30</td><td align="center">0.50</td></tr><tr><td><bold>1.00</bold></td><td align="center">40.84</td><td align="center">98.39</td><td align="center">82.95</td><td align="center">0.53</td><td align="center">26.37</td><td align="center">99.72</td><td align="center">93.00</td><td align="center">0.46</td></tr></tbody></table><table-wrap-foot><p>Bold are performances with maximum MCC (Threshold 0.0 or close to 0.0 preferred).</p><p>Bold and italic are performances where gap between sensitivity and specificity are minimum.</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Classification of different uridine modifications</title>
      <p>In the tRNA-136 dataset, ~72% of modified uridines belonged to either Pseudouridine or Dihydrouridine. Therefore, we developed separate prediction models for these two major classes of UMs.</p>
      <sec id="Sec11">
        <title>Prediction of pseudouridine (Y) modification</title>
        <p>We used patterns of Pseudouridine as positives and all other UMs as negatives. The maximum performance MCC 0.93 and 0.96 was achieved using SVM models based on BPP and tRNAscan-SE based approach respectively. We achieved best threshold-independent performance AUC 0.986, 0.985 and 0.983 using SVM models based on BPP, tRNAscan-SE predicted structures and hybrid approach respectively (Figure <xref rid="Fig4" ref-type="fig">4</xref>b).</p>
      </sec>
      <sec id="Sec12">
        <title>Prediction of Dihydrouridine (D) modification</title>
        <p>The patterns of Dihydrouridines were used as positive and other patterns of UMs were used as negatives. The BPP approach achieved 0.90 MCC and 0.986 AUC whereas tRNAscan-SE based approach achieved 0.95 MCC and 0.985 AUC. The hybrid approach predicted all Dihydrouridines correctly (100% sensitivity) with 97.36% specificity, 98.18% accuracy, 0.96 MCC and 0.991 AUC values (Figure <xref rid="Fig4" ref-type="fig">4</xref>c).</p>
      </sec>
    </sec>
    <sec id="Sec13">
      <title>Evaluation of developed models on the kingdom-wise independent datasets</title>
      <p>In the second step, we wanted to see the performance of a common prediction model (based on the tRNA-136 dataset) on the kingdom-wise independent datasets. We used newly added tRNA sequences (which were not used for the common prediction model development; see material and methods section) of MODOMICS databaset [<xref ref-type="bibr" rid="CR40">40</xref>] update 2012, for the performance evaluation of previously developed model. We achieved 0.911, 0.949, 0.919, 0.910, 0.936, 0.789, 0.930 and 0.944 of AUC for the prediction of modified uridines of All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig5" ref-type="fig">5</xref>a). The model was not good to predict UMs in the mitochondrial tRNAs because structure of 18 out of total 93 mitochondrial tRNAs were not predicted. Therefore, we also applied previously developed BPP approach based model (based on tRNA-136 dataset), where structural information was not required and achieved 0.892, 0.943, 0.916, 0.886, 0.919, 0.748, 0.892 and 0.945 of AUC for the prediction of modified uridines of All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig5" ref-type="fig">5</xref>b). Here also prediction performance was low for mitochondrial tRNAs. In the most of cases performances were decreased when we applied BPP instead of hybrid approach. It means structural information provided important information for the both, common (all) and kingdom-wise predictions.<fig id="Fig5"><label>Figure 5</label><caption><p><bold>ROC plots showing kingdom-wise prediction performances of (a) hybrid and (b) binary approach on the independent datasets.</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig5_HTML" id="d30e1355"/></fig></p>
      <p>Hybrid approach based models achieved 0.84, 0.81, 0.90, 0.84, 0.82, 0.85, 0.97 and 0.75 of MCC for the pseudouridine prediction of All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively. In the dihydrouridine prediction, hybrid model achieved 0.90, 0.97, 0.89, 0.90, 0.88, 0.89 and 0.92 of MCC for the modified (dihydrouridine) uridines of All, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively.</p>
    </sec>
    <sec id="Sec14">
      <title>Kingdom-wise prediction model development</title>
      <p>In the third and last step, we used new kingdom-wise datasets from MODOMICS database [<xref ref-type="bibr" rid="CR40">40</xref>] update 2012. It was shown in the previous approaches and evaluated by independent datasets that hybrid approach performed better if the structure predicted by tRNAscan-SE otherwise BPP approach can also be use as an alternative. Therefore, we have developed kingdom-specific prediction models using tRNA-419 and tRNA-471 datasets (See details in the material and method section). The tRNA-471 is a 50% non-redundant and containing 54 archaeal, 124 bacterial, 279 eukaryotic (142 cytosolic, 110 mitochondrial and 27 plastidic) and 14 viral tRNAs. First we developed a BPP approach based common prediction model for modified uridine prediction and achieved 0.917 of AUC. When we analyzed the kingdom-wise performance in this common prediction than we found 0.867, 0.901, 0.932, 0.946, 0.915, 0.974 and 0.837 of AUC for the Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig6" ref-type="fig">6</xref>a). In the kingdom-wise individual (separately for each kingdom/orgenelle) model development, we achieved 0.970, 0.907, 0.925, 0.949, 0.868, 0.883 and 0.867 of AUC for the Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig6" ref-type="fig">6</xref>b). These kingdom-wise individual models were also developed for the pseudouridine and dihydrouridine. In the pseudouridine prediction, we achieved 0.974, 0.933, 0.987, 0.964, 0.963, 0.952, 0.975 and 0.880 of AUC for the All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig6" ref-type="fig">6</xref>c). We also achieved 0.987, 0.997, 0.977, 0.981, 0.970, 0.977 and 0.895 of AUC for the dihydrouridine prediction of All, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig6" ref-type="fig">6</xref>d).<fig id="Fig6"><label>Figure 6</label><caption><p><bold>ROC plots showing BPP approach based prediction performances on the kingdom-wise datasets (tRNA-471) for the prediction of (a) uridine modifications on the common prediction model, (b) uridine modifications on the kingdom-wise individual (separately for each kingdom/orgenelle) models, (c) Pseudouridine modification on the kingdom-wise separate models and (d) Dihydrouridine modification on the kingdom-wise separate models.</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig6_HTML" id="d30e1390"/></fig></p>
      <p>In the hybrid approach, we used tRNA-419 (50% non-redundant) dataset instead of tRNA-471, because tRNAscan-SE software was not predicted structures of 52 tRNA sequences. The tRNA-419 dataset containing 53 archaeal, 121 bacterial, 233 eukaryotic (114 cytosolic, 92 mitochondrial and 27 plastidic) and 12 viral tRNAs. A common prediction model for modified uridine prediction achieved 0.941 of AUC in comparison to 0.917 AUC of BPP approach. In this performance of 0.941 AUC, kingdom-wise prediction performances were 0.962, 0.930, 0.962, 0.962, 0.962, 1.00 and 0.952 of AUC for the Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig7" ref-type="fig">7</xref>a). In the kingdom-wise individual model development, we achieved 0.987, 0.931, 0.953, 0.959, 0.940, 0.924 and 0.915 of AUC for the Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig7" ref-type="fig">7</xref>b). These kingdom-wise individual models were also developed for the pseudouridine and dihydrouridine. The pseudouridine prediction performances were 0.986, 0.945, 0.996, 0.985, 0.981, 0.992, 0.999 and 0.961 of AUC for the All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig7" ref-type="fig">7</xref>c). This hybrid approach achieved 0.994, 0.999, 0.990, 0.983, 0.997, 0.988 and 0.993 of AUC for the dihydrouridine prediction of All, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively (Figure <xref rid="Fig7" ref-type="fig">7</xref>d). The dihydrouridine modifications were absent in the archaeal tRNA sequences. These results showed that Hybrid approach performed better in comparison to BPP approach, whether kingdom-wise performances in the common method or individually developed methods. Hybrid approach also performed better than BPP for the prediction of pseudouridine and dihydrouridine.<fig id="Fig7"><label>Figure 7</label><caption><p><bold>ROC plots showing hybrid approach based prediction performances on the kingdom-wise datasets (tRNA-419) for the prediction of (a) uridine modifications on the common prediction model, (b) uridine modifications on the kingdom-wise individual (separately for each kingdom/orgenelle) models, (c) Pseudouridine modification on the kingdom-wise separate models and (d) Dihydrouridine modification on the kingdom-wise separate models.</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig7_HTML" id="d30e1416"/></fig></p>
      <p>Although, our main focused was to predict UMs in tRNA sequences and further classify them into pseudouridine and dihydrouridine modifications but we also tried to develop method for the third (~11% of all UMs) most abundant UM- 5-methyl-uridine.</p>
    </sec>
    <sec id="Sec15">
      <title>Prediction of 5-methyl-uridine (T) modification</title>
      <p>The tRNA-136 dataset contains 14.2% UMs as 5-methyl-uridines. We analyzed kingdom-wise patterns and found that this modification is present only at a well-known conserved site GTYC (GUUC in the WebLogo) of the T-Stem Loop (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10). Therefore, it is easy to predict this modification, if boundaries of loops (mainly VL and TSL) are correctly predicted in the tRNA. The patterns of 5-methyl-uridine were used as positives and other UMs were used as negatives for developing SVM-based models. First we have used tRNA-136 and developed common model for the prediction of 5-methyl-uridines. In the threshold-dependent performances, BPP approach achieved 97.9% sensitivity, 97.36% specificity, 97.43% accuracy and 0.90 MCC whereas tRNAscan-SE achieved 96.84% sensitivity, 94.54% specificity, 94.86% accuracy and 0.82 MCC. Hybrid approach increased the performance and achieved 94.74% sensitivity, 98.42% specificity, 97.88% accuracy and 0.92 MCC. The threshold-independent performance of BPP, tRNAscan-SE and Hybrid approaches achieved 0.991, 0.971 and 0.993 AUC values (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11a). On the independent datasets (which were not used in the tRNA-136 dataset), Hybrid approach based model achieved 0.90, 0.97, 0.93, 0.93, 0.98, 0.90 and 0.78 of MCC for the 5-methyl-uridine prediction of All, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively. Finally, we applied BPP (tRNA-471 dataset) and hybrid (tRNA-419 dataset) approaches and achieved 0.993, 0.997, 0.996, 0.997, 0.997, 1.00 and 0.985 of AUC for BPP (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure 11b) and 0.993, 0.995, 0.996, 0.996, 0.998, 1.00 and 0.985 of AUC for hybrid approach (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure 11c) for the All, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively. The 5-methyl-uridine modification was absent in the archaeal tRNA sequences.</p>
    </sec>
    <sec id="Sec16">
      <title>Prediction of other uridine modifications</title>
      <p>To see whether SVM based machine learning can discriminate these three (Y, D and T) modifications from other UMs (remaining ~12%) or not, we applied same above-mentioned strategy. We used tRNA-136 dataset and patterns of Y, D and T as negatives and patterns of other UMs as positives. The BPP approach performed 66.26% sensitivity, 98.42% specificity, 93.95% accuracy and 0.73 MCC. The structural information of tRNAscan-SE based approach achieved 52.16% sensitivity, 99.82% specificity, 93.19% accuracy and 0.69 MCC. The Hybrid approach increased performance significantly and achieved 75.96% sensitivity, 97.89% specificity, 94.86% accuracy and 0.78 MCC. The threshold-independent performance of BPP, tRNAscan-SE and Hybrid approaches achieved 0.924, 0.868 and 0.922 AUC values (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S12a).</p>
      <p>On the independent datasets, Hybrid approach based model achieved 0.58, 0.77, 0.86, 0.41, 0.38, 0.49, 0.53 and 0.64 of MCC for the other modified (except Y, D and T) uridines of All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively. The BPP (tRNA-471 dataset) and hybrid (tRNA-419 dataset) approaches were achieved 0.905, 0.933, 0.974, 0.845, 0.847, 0.916, 0.905 and 0.860 of AUC for BPP (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure 12b) and 0.925, 0.947, 0.976, 0.889, 0.877, 0.967, 0.867 and 0.995 of AUC for hybrid approach (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure 12c) for the All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-mito, Eukaryote-plastid and Viruses respectively. The prediction performances were low in comparison to Y, D and T because here we used total 19 different types of modifications together as positives. In order to implement the prediction model in the form of web-server, it was necessary to develop a separate prediction model for other UMs (remaining ~12%).</p>
      <p>In conclusion, SVM-based prediction modules performed better with hybrid approach of BPP and tRNAscan-SE based structural information. The details of all results given in an excel file (see Additional file <xref rid="MOESM2" ref-type="media">2</xref>), contain results of all approaches, window sizes at all (−1.0 to 1.0) thresholds and ROC graphs.</p>
    </sec>
  </sec>
  <sec id="Sec17" sec-type="discussion">
    <title>Discussion</title>
    <p>In present study, we retrieved information of 218 and 642 modified tRNAs from MODOMICS database [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Initially, we analyzed all 642 tRNA modifications and observed that majority (55.85%) of modifications were uridine-derived (Figure <xref rid="Fig1" ref-type="fig">1</xref>) and 29.27% uridines of all uridines were modified. Therefore, we selected only UMs for further study. The kingdom-wise differences between flanking nucleotides of modified and unmodified uridines were observed (Figure <xref rid="Fig2" ref-type="fig">2</xref>). It may be due to the pattern-wise preference of modifying enzymes. In past, sliding window-based approach was widely used for nucleotide/residue level predictions [<xref ref-type="bibr" rid="CR46">46</xref>]. It requires complete optimization of all window sizes for every prediction. We created different lengths (3–25) of sliding window patterns and various approaches of compositions; BPP and structural information were applied. First we used tRNA-136 dataset for the common prediction model and evaluated using 5-fold cross validation technique. In compositions based input features of MNC, DNC and TNC achieved AUC of 0.76, 0.840 and 0.865 respectively. The BPP increased the prediction performance to AUC of 0.924 AUC because it provided information of nucleotides with their positions whereas compositions based approaches have only frequencies or one/two neighboring nucleotide information. All tRNA fold into well defined structures with some regions and loops more prone to modification thereby making the structural information useful for prediction. Consequently, secondary structures provided by tRNAscan-SE software achieved AUC of 0.925. When the structural information of tRNAscan-SE software predicted boundaries of different loops was combined with positional information of nucleotides in the form of BPP; performance increased significantly and achieved AUC of 0.936 (Figure <xref rid="Fig4" ref-type="fig">4</xref>a). We have also analyed the effect of window size on the prediciton performance and found that performance continously increased in 3–15 window size and saturated between the 17–25 window sizes (Figure <xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8"><label>Figure 8</label><caption><p><bold>Prediction performance (MCC) of BPP and tRNAscan-SE based approaches using different window sizes.</bold></p></caption><graphic xlink:href="12859_2014_6647_Fig8_HTML" id="d30e1495"/></fig></p>
    <p>In the second step, we evaluated previously developed (based on tRNA-136) models on the independent datasets and analyzed the kingdom wise performances. Hybrid approach performed well for All, Archaea, Bacteria, Eukaryote-all, Eukaryote-cyto, Eukaryote-plastid and Viruses but not performed for Eukaryote-mito (Figure <xref rid="Fig5" ref-type="fig">5</xref>). It may be because tRNA-136 contained only 18 mitochondrial tRNAs of <italic>Saccharomyces cerevisiae</italic> and developed model was not good enough to predict UMs in the mitochondrial tRNAs from other eukaryotes. Although, mitochondrial tRNAs have evolutionary connection with bacterial tRNAs but our results showed that prokaryotic datasets based model cannot predict the uridine modifications in the mitochondrial tRNAs.</p>
    <p>In the last step, we used BPP (based on tRNA-471 dataset) and hybrid (based on tRNA-419 dataset) approach for the final kingdom-specific prediction models and evaluated using five-fold cross validation technique. The hybrid approach performed better than simple BPP approach in all kingdoms. It means structural information provided important information, when it integrated with BPP (Figures <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref>). Hybrid approach achieved 0.941 AUC for all tRNAs but when applied separately for Archaea and Eukaryotes, it increased to the AUC of 0.987 and 0.953 respectively. We found that hybrid approach of BPP and tRNAscan-SE was efficient not only to predict UMs but also to classify them into pseudouridine and dihydrouridine (Figure <xref rid="Fig7" ref-type="fig">7</xref>). The BPP approach can also be useful as an alternative, if structure of tRNA is not available (Figure <xref rid="Fig6" ref-type="fig">6</xref>). We also developed models for the third most abundant (~11% of all UMs) 5-methyl-uridines UMs.</p>
    <p>A recent study of Novoa et al. [<xref ref-type="bibr" rid="CR38">38</xref>] showed that additional information of two modifications (I<sub>34</sub> and xo<sup>5</sup>U<sub>34</sub>) improved correlation between codon usage and tRNA gene frequencies in all kingdoms significantly. Modifications in ASLs are very important given the fact that modified U<sub>34</sub> acts as proton donor/acceptor, coordinates metal ions and has great diverse chemistry [<xref ref-type="bibr" rid="CR27">27</xref>] ultimately affecting codon-anticodon recognition. The ASLs, DSLs, TSLs and VLs of different tRNAs vary in sequence and the type of modification. Modification of seven-nucleotide ASLs (especially wobble 34 and purine 37 site) is more important because global conformation of ASLs decides entry of anticodon domain into the ribosomal A-site [<xref ref-type="bibr" rid="CR13">13</xref>] and affects translation speed [<xref ref-type="bibr" rid="CR47">47</xref>]. Data availability is the main criterion for the development of any prediction model and the number of uridine modifications (55.85%) is very high in comparison to guanine (19.71%), adenine (12.28%) and cytosine (10.41%) modifications. Therefore, we developed prediction models for UMs only. Many RNA modifications are not essential for cell survival. Probably these modifications are less important or not fully explored yet considering the fact that many DNA and protein modifications are also not essential. Precise roles of most of tRNA modifications are poorly understood and their industrial applications are still unexplored. Pseudouridine provides rigidity whereas dihydrouridine is the only non-aromatic nucleoside and provides flexibility to the tRNA structure. In this era of synthetic biology, better understanding of tRNA modifications will help in the better tRNA designing, incorporation of novel amino acids and production of new proteins. In particular, biochemists have great opportunity to play with the chemistry of wobble base and expand amino acid boundaries.</p>
  </sec>
  <sec id="Sec18" sec-type="conclusions">
    <title>Conclusion</title>
    <p>To conclude, the present study is a systematic attempt to predict and classify UMs in tRNA sequences. We developed separate and kingdom-wise predictors for the prediction of UMs and thereafter classify them into Pseudouridines, Dihydrouridines and 5-methyl-uridine and other UMs. We found that hybrid approach of binary and structural information is most suitable for the SVM based prediction of UMs. These prediction modules have been implemented in a ‘tRNAmod’ web-server. This server can predict and classify UMs from tRNA sequences or whole genome of any organism.</p>
  </sec>
  <sec id="Sec19" sec-type="methods">
    <title>Methods</title>
    <sec id="Sec20">
      <title>Datasets</title>
      <p>In this study, two different version of MODOMICS database update 2008 [<xref ref-type="bibr" rid="CR39">39</xref>] and update 2012 [<xref ref-type="bibr" rid="CR40">40</xref>] have been used. Update 2008 and 2012 of MODOMICS database were containing 218 and 642 tRNA (modified) sequences respectively.</p>
      <sec id="Sec21">
        <title>MODOMICS database update 2008</title>
        <p>We extracted 43 different types of modification in total 218 (35 <italic>Bacillus subtilis</italic>, 47 <italic>Escherichia coli</italic>, 41 <italic>Halobacterium volcanii</italic>, 29 <italic>Mycoplasma capricolum</italic> and 66 <italic>Saccharomyces cerevisiae</italic>) modified tRNA sequences from MODOMICS database [<xref ref-type="bibr" rid="CR39">39</xref>]. Out of the total 17088 bases in these sequences, 1674 bases are modified and 15414 are unmodified. The base-specific contribution in modifications of uridine, guanine, adenine and cytosine are 61.4%, 17.2%, 11.2% and 10.2% respectively.</p>
      </sec>
      <sec id="Sec22">
        <title>tRNA-136</title>
        <p>To develop a prediction method, it is important to create non-redundant dataset because prediction of modified base in diverse sequences is a major challenge. In the case of RNA sequences 50% non-redundancy level is sufficient to evaluate prediction model and also most of tools are not reliable for generating more stringent redundancy level for nucleotide sequences. Therefore, we created 50% non-redundant (NR) dataset of 136 (16 <italic>Bacillus subtilis</italic>, 33 <italic>Escherichia coli</italic>, 31 <italic>Halobacterium volcanii</italic>, 9 <italic>Mycoplasma capricolum</italic> and 47 <italic>Saccharomyces cerevisiae</italic>) tRNA sequences from MODOMICS database update 2008 using BLASTCLUST software and termed it as ‘tRNA-136’. The tRNA-136 dataset contains a total of 10654 bases, out of which 1095 are modified (10.28%) and 9559 are unmodified bases. It includes 40 different types of modifications. In tRNA-136 dataset, 661 (60.4%) modified-bases are uridine-derived. Most of uridine modifications belong to Pseudouridine (40.5%), Dihydrouridine (31.3%), 5-methyl-uridine (14.2%) and remaining 14% are other UMs.</p>
      </sec>
      <sec id="Sec23">
        <title>MODOMICS database update 2012</title>
        <p>We extracted total 642 (413 eukaryotic, 152 bacterial, 60 archaeal and 17 viral) modified tRNA sequences from MODOMICS database [<xref ref-type="bibr" rid="CR40">40</xref>], which contained ~60 type of modifications from 77 different organisms (49 eukaryotes, 17 bacteria, 7 archaea and 4 viruses). Total ~13% bases were modified and uridine-, guanine-, adenine- and cytosine-derived modified bases were 55.85%, 19.71%, 12.28% and 10.41% of total modified bases respectively (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).</p>
      </sec>
      <sec id="Sec24">
        <title>Independent datasets</title>
        <p>In order to create kingdom-wise independent datasets, we used only newly updated (organism-wise) tRNA sequences of MODOMICS database update 2012 and excluded all the tRNA sequences (all the tRNAs of <italic>Bacillus subtilis</italic>, <italic>Escherichia coli</italic>, <italic>Haloferax volcanii</italic> (formerly named as <italic>Halobacterium volcanii)</italic>, <italic>Mycoplasma capricolum</italic> and <italic>Saccharomyces cerevisiae</italic>) of MODOMICS update 2008. In this way, we created kingdom-wise independent datasets of all 407 tRNAs, which contains 19 archaeal, 41 bacterial, 330 eukaryotic (199 cytosolic, 93 mitochondrial and 38 plastidic) and 17 viral tRNA sequences. These independent datasets were used for the kingdom-wise performance evaluation of common prediction model (based on tRNA-136).</p>
      </sec>
      <sec id="Sec25">
        <title>tRNA-471</title>
        <p>We used all 642 tRNAs of MODOMICS database update 2012 and created 50% non-redundant (NR) dataset of 471 tRNA sequences using BLASTCLUST software and termed it as ‘tRNA-471’. It contains 54 archaeal, 124 bacterial, 279 eukaryotic (142 cytosolic, 110 mitochondrial and 27 plastidic) and 14 viral tRNA sequences. We used these kingdom-wise datasets for the model development of BPP approach.</p>
      </sec>
      <sec id="Sec26">
        <title>tRNA-419</title>
        <p>In the hybrid approach, tRNAscan-SE software was not predicted structure of 52 tRNAs from tRNA-471 dataset. Therefore, we created separate dataset of 419 tRNAs and termed as ‘tRNA-419’. It contains 53 archaeal, 121 bacterial, 233 eukaryotic (114 cytosolic, 92 mitochondrial and 27 plastidic) and 12 viral tRNA sequences. In the hybrid approach, we used these kingdom-wise datasets for the prediction model development.</p>
        <p>Both the dataset, data-218 (MODOMICS database update 2008) and data-642 (MODOMICS database update 2012) have been provided in the Additional file <xref rid="MOESM3" ref-type="media">3</xref> and Additional file <xref rid="MOESM4" ref-type="media">4</xref> respectively. The nomenclature of modification used from MODOMICS database, which has been also provided in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
      </sec>
    </sec>
    <sec id="Sec27">
      <title>Creation of sliding windows</title>
      <p>In past, sliding window-based strategies have been successfully applied for residue level predictions [<xref ref-type="bibr" rid="CR46">46</xref>]. Thus, we created and optimized different lengths of window size (3–25) of odd numbers (eg. 3, 5, 7,…, 25). If the central nucleotide of window pattern is modified then it was assigned as positive pattern otherwise assigned as negatives. In this way, we created window patterns for each nucleotide in the tRNA-136 dataset. To generate fixed length window size of terminal nucleotides, we added a dummy ‘X’ nucleotide in both terminals of each sequence. The number of dummy nucleotides was calculated with (L-1)/2 formula (where L is the length of pattern). In this study, we used maximum window size 25 because the average length of tRNA is 77 (each containing 3 loops) and large window sizes are not advisable for better machine learning. Thus, we preferred well performing small window to large window sizes.</p>
    </sec>
    <sec id="Sec28">
      <title>Compositions-based approaches</title>
      <p>In this approach, we calculated mono-nucleotide composition (MNC), di-nucleotide composition (DNC) and tri-nucleotide composition (TNC) of tRNA sequences. After adding dummy ‘X’ at both terminals, total number of nucleotides reached to five (A, C, G, U and X). The MNC, DNC and TNC generated input features of 5 (A, C, G, U and X), 25 (AA, AC, AG, CG, AU,…, XX) and 125 (AAA, AAC, AAG,…, XXX) dimensions of vector.</p>
    </sec>
    <sec id="Sec29">
      <title>Binary approach</title>
      <p>As discussed above, positive and negative patterns of sliding windows were created but numerical representation of these patterns is necessary for SVM-based machine learning. Thus, we applied binary profile of patterns (BPP) approach, which gives nucleotide (or amino acids) information as well their positional (sequential) information [<xref ref-type="bibr" rid="CR46">46</xref>]. In BPP, we represented A, C, G, U and X nucleotides with {1,0,0,0,0}, {0,1,0,0,0}, {0,0,1,0,0}, {0,0,0,1,0} and {0,0,0,0,1} respectively. The number of total input features generated by BPP was five times more than used window size (e.g. 17-length window generates total 85 (17×5) input features).</p>
    </sec>
    <sec id="Sec30">
      <title>Structure-based approaches</title>
      <p>All tRNA sequences fold into well-defined structures, thus structural information was used for SVM-based machine learning. The secondary structures of all tRNAs were predicted using three different software: RNAfold [<xref ref-type="bibr" rid="CR43">43</xref>], IPknot [<xref ref-type="bibr" rid="CR44">44</xref>] and tRNAscan-SE [<xref ref-type="bibr" rid="CR45">45</xref>]. We converted all the secondary structural information into binary pattern for prediction model development. Here also dummy ‘X’ were used for the terminal nucleotides in order to create fixed length patterns. RNAfold gives three types of secondary structures, thus we represented small open bracket, small close bracket, dot and X as {1,0,0,0}, {0,1,0,0}, {0,0,1,0} and {0,0,0,1} respectively. IPknot predicted five different types secondary structures, which include additional information of pseudoknots in the form of square brackets (open and close). Thus, binary representations of small open bracket, small close bracket, square open bracket, square close bracket, dot and dummy X were {1,0,0,0,0}, {0,1,0,0,0}, {0,0,1,0,0}, {0,0,0,1,0} and {0,0,0,0,1} respectively. The tRNAscan-SE predicts tRNA secondary structures specifically and gives three different types secondary structures. We represented &lt;, &gt;, dot and X in the binary form of {1,0,0,0}, {0,1,0,0}, {0,0,1,0} and {0,0,0,1} respectively. In this way, we converted all the secondary structural information into machine learning input format and developed separate prediction model for each software.</p>
    </sec>
    <sec id="Sec31">
      <title>Hybrid approach</title>
      <p>The hybrid approach is an integration of two or more approaches. In this study, we observed that binary information of BPP (85 features of 17-length window) and predicted structures of tRNAscan-SE (76 input features of 19-length window) performed well individually. Thus, we integrated these two approaches and created 161 (85 + 76) input features. This hybrid approach, provided both nucleotide-wise positional information and structural information further improving prediction performance.</p>
    </sec>
    <sec id="Sec32">
      <title>Support vector machine</title>
      <p>SVM is widely used and highly successful machine learning technique for the biological predictions [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. It is based on the structural risk minimization principle of statistical learning theory. SVMs are a set of supervised learning methods, which can be used for both classification and regression mode [<xref ref-type="bibr" rid="CR50">50</xref>]. We implemented SVM<sup>light</sup> (version 6.02) package for the development of all prediction models [<xref ref-type="bibr" rid="CR51">51</xref>]. It provides several parameters and kernels (e.g. linear, polynomial, radial basis function, and sigmoid) or any user-defined kernel. The svm_learn and svm_classify are two main softwares in this package. First, we used svm_learn for training of known examples and building of prediction models. After training, learned models predicted unknown examples (in five-fold cross-validation) using svm_classify. We tried various parameters and kernels and found that radial basis function (RBF) kernel performed well in all cases.</p>
    </sec>
    <sec id="Sec33">
      <title>Five-fold cross validation</title>
      <p>In past, various prediction performance evaluation techniques have been applied such as leave-one out cross-validation (LOOCV) or jack-knife test, n-fold cross validation technique [<xref ref-type="bibr" rid="CR52">52</xref>]. Though, jack-knife test is best for performance evaluation but it is a time-consuming process. Thus, we used 5-fold cross validation technique, which is highly used in the performance evaluation of biological predictions [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. In 5-fold cross validation, we divided both positive and negative samples into five subsets separately. We created five sets and each set containing one positive and one negative subset. The four subsets have been used for training and the remaining fifth subset was used for testing and calculating the performance. This step was repeated five times in such a way that each subset was used once for testing. The final performance is an average performance of all five testing sets.</p>
    </sec>
    <sec id="Sec34">
      <title>Evaluation parameters</title>
      <p>The prediction performance of each model was calculated in the form of sensitivity (Equation <xref rid="Equ1" ref-type="">1</xref>), specificity (Equation <xref rid="Equ2" ref-type="">2</xref>), accuracy (Equation <xref rid="Equ3" ref-type="">3</xref>) and MCC (Equation <xref rid="Equ4" ref-type="">4</xref>) values. These are well-established evaluation parameters for biological prediction [<xref ref-type="bibr" rid="CR54">54</xref>].
<disp-formula id="Equ1"><label>1</label><graphic xlink:href="12859_2014_6647_Equ1_HTML.gif" position="anchor"/></disp-formula><disp-formula id="Equ2"><label>2</label><graphic xlink:href="12859_2014_6647_Equ2_HTML.gif" position="anchor"/></disp-formula><disp-formula id="Equ3"><label>3</label><graphic xlink:href="12859_2014_6647_Equ3_HTML.gif" position="anchor"/></disp-formula><disp-formula id="Equ4"><label>4</label><graphic xlink:href="12859_2014_6647_Equ4_HTML.gif" position="anchor"/></disp-formula></p>
      <p>Where TP, TN, FP and FN are True Positives, True Negative, False Positives and False Negatives respectively.</p>
      <p>Above-mentioned evaluation parameters are threshold-dependent so we also calculated threshold-independent performance in terms of Area Under Curve (AUC) values using Receiver Operating Curve (ROC) plots. It is a plot between true positive rate and false positive rate.</p>
      <p>The tRNAmod web-server gives probability score for each prediction. To calculate this score we used Equation <xref rid="Equ5" ref-type="">5</xref>, where SVM score of more than 1.5 and less than −1.5 was fixed to 1.5 and −1.5 respectively.
<disp-formula id="Equ5"><label>5</label><graphic xlink:href="12859_2014_6647_Equ5_HTML.gif" position="anchor"/></disp-formula></p>
      <p>The probability score range varies from 0–9 only. We adopted this strategy because it is easy to display this probability score with tRNA sequence in tRNAmod web-server.</p>
    </sec>
    <sec id="Sec35">
      <title>Description of tRNAmod web-server</title>
      <p>A user-friendly web-server tRNAmod was developed for the kingdom-wise prediction of UMs in tRNA sequence. There are two different prediction options available in tRNAmod, (1) Sequence-level prediction and (2) Genome-wide prediction. In the sequence-level prediction, it requires tRNA sequences in FASTA format and it will directly predict UMs in the given tRNAs. In the Genome-wide prediction, it requires whole genome sequence (also in FASTA fromat). First, it will extract tRNA sequences from the submitted genome using tRNAscan-SE [<xref ref-type="bibr" rid="CR45">45</xref>] software then tRNAmod will predict UMs in extracted tRNA sequences. It will show the probability score (ranges 0–9) for each predicted UMs. The server shows secondary structure information of tRNA using tRNAscan-SE. A java-based applet VARNA [<xref ref-type="bibr" rid="CR55">55</xref>] also has been implemented for structure visualization of tRNA, where predicted UMs will be highlighted in the tRNA structure. The tRNAmod is freely available for the help of global scientific community and is available at <ext-link ext-link-type="uri" xlink:href="http://crdd.osdd.net/raghava/trnamod">http://crdd.osdd.net/raghava/trnamod</ext-link>.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Electronic supplementary material</title>
    <sec id="Sec36">
      <supplementary-material content-type="local-data" id="MOESM1">
        <media xlink:href="12859_2014_6647_MOESM1_ESM.doc">
          <caption>
            <p>Additional file 1: Figure S1: Weblogo of tRNA sequences in the standard representation of 1–99 positions. <bold>Figure S2.</bold> Kingdom-wise percent distribution of different base-specific modifications. <bold>Figure S3.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using MNC approach. <bold>Figure S4.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using DNC approach. <bold>Figure S5.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using TNC approach. <bold>Figure S6.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using binary approach. <bold>Figure S7.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using RNAfold based approach. <bold>Figure S8.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using IPknot based approach. <bold>Figure S9.</bold> A ROC plot showing prediction performances of uridine modifications of different window sizes using tRNAscan-SE based approach. <bold>Figure S10.</bold> Kingdom-wise WebLogos of 5-methyl-uridine using 15-length sliding window patterns (central 8th position for 5-methyl-uridine). <bold>Figure S11.</bold> ROC plots showing performances for the prediction of 5-methyl-uridine (T) on the (a) tRNA-136 dataset, (b) BPP appraoch of tRNA-471 dataset and (c) hybrid approach of tRNA-419 dataset. <bold>Figure S12.</bold> ROC plots showing performances for the prediction of other uridines (except Y, D and T) modifications on the (a) tRNA-136 dataset, (b) BPP appraoch of tRNA-471 dataset and (c) hybrid approach of tRNA-419 dataset. <bold>Table S1.</bold> Modification-wise distribution of 642 tRNAs of the MODOMICS database. The nomenclature of modification used from MODOMICS database. (DOC 3 MB)</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2">
        <media xlink:href="12859_2014_6647_MOESM2_ESM.xls">
          <caption>
            <p>Additional file 2:
<bold>Contains the detailed results of different approaches at different window sizes and thresholds.</bold>
(XLS 891 KB)</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3">
        <media xlink:href="12859_2014_6647_MOESM3_ESM.txt">
          <caption>
            <p>Additional file 3:
<bold>Contains the information of 218 modified tRNA from MODOMICS database update 2008.</bold>
(TXT 45 KB)</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM4">
        <media xlink:href="12859_2014_6647_MOESM4_ESM.txt">
          <caption>
            <p>Additional file 4:
<bold>Contains the information of 642 modified tRNA from MODOMICS database update 2012.</bold>
(TXT 133 KB)</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Competing interests</bold>
      </p>
      <p>The authors declare that they have no competing interests.</p>
    </fn>
    <fn>
      <p>
        <bold>Authors’ contributions</bold>
      </p>
      <p>BP created dataset, developed the SVM models, created the backend web server and the front end user interface. GPSR conceived the project, coordinated it and refined the manuscript drafted by BP. All the authors have read and approved final manuscript.</p>
    </fn>
  </fn-group>
  <ack>
    <p>Authors are thankful to funding agencies Council of Scientific and Industrial Research (project OSDD and GENESIS BSC0121) and Department of Biotechnology (project BTISNET), Government of India. This report has Institute of Microbial Technology (IMTECH) communication no. 055/2012.</p>
  </ack>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Helm</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Post-transcriptional nucleotide modification and alternative folding of RNA</article-title>
        <source>Nucleic Acids Res</source>
        <year>2006</year>
        <volume>34</volume>
        <issue>2</issue>
        <fpage>721</fpage>
        <lpage>733</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkj471</pub-id>
        <?supplied-pmid 16452298?>
        <pub-id pub-id-type="pmid">16452298</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Helm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brulé</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Degoul</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Cepanec</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Leroux</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Giegé</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Florentz</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>The presence of modified nucleotides is required for cloverleaf folding of a human mitochondrial tRNA</article-title>
        <source>Nucleic Acids Res</source>
        <year>1998</year>
        <volume>26</volume>
        <fpage>1636</fpage>
        <lpage>1643</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/26.7.1636</pub-id>
        <?supplied-pmid 9512533?>
        <pub-id pub-id-type="pmid">9512533</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Motorin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Helm</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>tRNA stabilization by modified nucleotides</article-title>
        <source>Biochemistry</source>
        <year>2010</year>
        <volume>49</volume>
        <fpage>4934</fpage>
        <lpage>4944</lpage>
        <pub-id pub-id-type="doi">10.1021/bi100408z</pub-id>
        <?supplied-pmid 20459084?>
        <pub-id pub-id-type="pmid">20459084</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chernyakov</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Whipple</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Kotelawala</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Grayhack</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Phizicky</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <article-title>Degradation of several hypomodified mature tRNA species in Saccharomyces cerevisiae is mediated by Met22 and the 5′-3′ exonucleases Rat1 and Xrn1</article-title>
        <source>Genes Dev</source>
        <year>2008</year>
        <volume>22</volume>
        <fpage>1369</fpage>
        <lpage>1380</lpage>
        <pub-id pub-id-type="doi">10.1101/gad.1654308</pub-id>
        <?supplied-pmid 18443146?>
        <pub-id pub-id-type="pmid">18443146</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alexandrov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chernyakov</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hiley</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Hughes</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Grayhack</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Phizicky</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <article-title>Rapid tRNA decay can result from lack of nonessential modifications</article-title>
        <source>Mol Cell</source>
        <year>2006</year>
        <volume>21</volume>
        <fpage>87</fpage>
        <lpage>96</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2005.10.036</pub-id>
        <?supplied-pmid 16387656?>
        <pub-id pub-id-type="pmid">16387656</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kadaba</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Krueger</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Trice</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Krecic</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Hinnebusch</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae</article-title>
        <source>Genes Dev</source>
        <year>2004</year>
        <volume>18</volume>
        <fpage>1227</fpage>
        <lpage>1240</lpage>
        <pub-id pub-id-type="doi">10.1101/gad.1183804</pub-id>
        <?supplied-pmid 15145828?>
        <pub-id pub-id-type="pmid">15145828</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
        </person-group>
        <article-title>Decoding the genome: a modified view</article-title>
        <source>Nucleic Acids Res</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>223</fpage>
        <lpage>238</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkh185</pub-id>
        <?supplied-pmid 14715921?>
        <pub-id pub-id-type="pmid">14715921</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Vendeix</surname>
            <given-names>FAP</given-names>
          </name>
          <name>
            <surname>Graham</surname>
            <given-names>WD</given-names>
          </name>
        </person-group>
        <article-title>tRNA’s wobble decoding of the genome: 40 years of modification</article-title>
        <source>J Mol Biol</source>
        <year>2007</year>
        <volume>366</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmb.2006.11.046</pub-id>
        <?supplied-pmid 17187822?>
        <pub-id pub-id-type="pmid">17187822</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dalluge</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Hashizume</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sopchik</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>McCloskey</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>Conformational flexibility in RNA: the role of dihydrouridine</article-title>
        <source>Nucleic Acids Res</source>
        <year>1996</year>
        <volume>24</volume>
        <fpage>1073</fpage>
        <lpage>1079</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/24.6.1073</pub-id>
        <?supplied-pmid 8604341?>
        <pub-id pub-id-type="pmid">8604341</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gustilo</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Vendeix</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
        </person-group>
        <article-title>tRNA’s modifications bring order to gene expression</article-title>
        <source>Curr Opin Microbiol</source>
        <year>2008</year>
        <volume>11</volume>
        <fpage>134</fpage>
        <lpage>140</lpage>
        <pub-id pub-id-type="doi">10.1016/j.mib.2008.02.003</pub-id>
        <?supplied-pmid 18378185?>
        <pub-id pub-id-type="pmid">18378185</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Krüger</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Pedersen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hagervall</surname>
            <given-names>TG</given-names>
          </name>
          <name>
            <surname>Sørensen</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>The modification of the wobble base of tRNAGlu modulates the translation rate of glutamic acid codons in vivo</article-title>
        <source>J Mol Biol</source>
        <year>1998</year>
        <volume>284</volume>
        <fpage>621</fpage>
        <lpage>631</lpage>
        <pub-id pub-id-type="doi">10.1006/jmbi.1998.2196</pub-id>
        <?supplied-pmid 9826503?>
        <pub-id pub-id-type="pmid">9826503</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yarian</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Townsend</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Czestkowski</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Sochacka</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Malkiewicz</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Guenther</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Miskiewicz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
        </person-group>
        <article-title>Accurate translation of the genetic code depends on tRNA modified nucleosides</article-title>
        <source>J Biol Chem</source>
        <year>2002</year>
        <volume>277</volume>
        <fpage>16391</fpage>
        <lpage>16395</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M200253200</pub-id>
        <?supplied-pmid 11861649?>
        <pub-id pub-id-type="pmid">11861649</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
        </person-group>
        <article-title>Bringing order to translation: the contributions of transfer RNA anticodon-domain modifications</article-title>
        <source>EMBO Rep</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>629</fpage>
        <lpage>635</lpage>
        <pub-id pub-id-type="doi">10.1038/embor.2008.104</pub-id>
        <?supplied-pmid 18552770?>
        <pub-id pub-id-type="pmid">18552770</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Murphy</surname>
            <given-names>FV</given-names>
          </name>
          <name>
            <surname>Ramakrishnan</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Malkiewicz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
        </person-group>
        <article-title>The role of modifications in codon discrimination by tRNA(Lys)UUU</article-title>
        <source>Nat Struct Mol Biol</source>
        <year>2004</year>
        <volume>11</volume>
        <fpage>1186</fpage>
        <lpage>1191</lpage>
        <pub-id pub-id-type="doi">10.1038/nsmb861</pub-id>
        <?supplied-pmid 15558052?>
        <pub-id pub-id-type="pmid">15558052</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hüttenhofer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Weiss-Brummer</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dirheimer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>RP</given-names>
          </name>
        </person-group>
        <article-title>A novel type of + 1 frameshift suppressor: a base substitution in the anticodon stem of a yeast mitochondrial serine-tRNA causes frameshift suppression</article-title>
        <source>EMBO J</source>
        <year>1990</year>
        <volume>9</volume>
        <fpage>551</fpage>
        <lpage>558</lpage>
        <?supplied-pmid 1689242?>
        <pub-id pub-id-type="pmid">1689242</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tuohy</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gesteland</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Atkins</surname>
            <given-names>JF</given-names>
          </name>
        </person-group>
        <article-title>Seven, eight and nine-membered anticodon loop mutants of tRNA(2Arg) which cause +1 frameshifting. Tolerance of DHU arm and other secondary mutations</article-title>
        <source>J Mol Biol</source>
        <year>1992</year>
        <volume>228</volume>
        <fpage>1042</fpage>
        <lpage>1054</lpage>
        <pub-id pub-id-type="doi">10.1016/0022-2836(92)90313-9</pub-id>
        <?supplied-pmid 1474576?>
        <pub-id pub-id-type="pmid">1474576</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Urbonavicius</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Durand</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Hagervall</surname>
            <given-names>TG</given-names>
          </name>
          <name>
            <surname>Björk</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Improvement of reading frame maintenance is a common function for several tRNA modifications</article-title>
        <source>EMBO J</source>
        <year>2001</year>
        <volume>20</volume>
        <fpage>4863</fpage>
        <lpage>4873</lpage>
        <pub-id pub-id-type="doi">10.1093/emboj/20.17.4863</pub-id>
        <?supplied-pmid 11532950?>
        <pub-id pub-id-type="pmid">11532950</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Phelps</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Malkiewicz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Joseph</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Modified nucleotides in tRNA(Lys) and tRNA(Val) are important for translocation</article-title>
        <source>J Mol Biol</source>
        <year>2004</year>
        <volume>338</volume>
        <fpage>439</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmb.2004.02.070</pub-id>
        <?supplied-pmid 15081802?>
        <pub-id pub-id-type="pmid">15081802</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sylvers</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ohtsuka</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Söll</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>A 2-thiouridine derivative in tRNAGlu is a positive determinant for aminoacylation by Escherichia coli glutamyl-tRNA synthetase</article-title>
        <source>Biochemistry</source>
        <year>1993</year>
        <volume>32</volume>
        <fpage>3836</fpage>
        <lpage>3841</lpage>
        <pub-id pub-id-type="doi">10.1021/bi00066a002</pub-id>
        <?supplied-pmid 8385989?>
        <pub-id pub-id-type="pmid">8385989</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giegé</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sissler</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Florentz</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Universal rules and idiosyncratic features in tRNA identity</article-title>
        <source>Nucleic Acids Res</source>
        <year>1998</year>
        <volume>26</volume>
        <fpage>5017</fpage>
        <lpage>5035</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/26.22.5017</pub-id>
        <?supplied-pmid 9801296?>
        <pub-id pub-id-type="pmid">9801296</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beuning</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Musier-Forsyth</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Transfer RNA recognition by aminoacyl-tRNA synthetases</article-title>
        <source>Biopolymers</source>
        <year>1999</year>
        <volume>52</volume>
        <fpage>1</fpage>
        <lpage>28</lpage>
        <pub-id pub-id-type="doi">10.1002/(SICI)1097-0282(1999)52:1&lt;1::AID-BIP1&gt;3.0.CO;2-W</pub-id>
        <?supplied-pmid 10737860?>
        <pub-id pub-id-type="pmid">10737860</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ibba</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Soll</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Aminoacyl-tRNA synthesis</article-title>
        <source>Annu Rev Biochem</source>
        <year>2000</year>
        <volume>69</volume>
        <fpage>617</fpage>
        <lpage>650</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev.biochem.69.1.617</pub-id>
        <?supplied-pmid 10966471?>
        <pub-id pub-id-type="pmid">10966471</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Safro</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Moor</surname>
            <given-names>NA</given-names>
          </name>
        </person-group>
        <article-title>Codases: fifty years after</article-title>
        <source>Mol Biol (Mosk)</source>
        <year>2009</year>
        <volume>43</volume>
        <fpage>230</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1134/S0026893309020046</pub-id>
        <pub-id pub-id-type="pmid">19425492</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crick</surname>
            <given-names>FH</given-names>
          </name>
        </person-group>
        <article-title>Codon–anticodon pairing: the wobble hypothesis</article-title>
        <source>J Mol Biol</source>
        <year>1966</year>
        <volume>19</volume>
        <fpage>548</fpage>
        <lpage>555</lpage>
        <pub-id pub-id-type="doi">10.1016/S0022-2836(66)80022-0</pub-id>
        <?supplied-pmid 5969078?>
        <pub-id pub-id-type="pmid">5969078</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nishimura</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Minor components in transfer RNA: their characterization, location, and function</article-title>
        <source>Prog Nucleic Acid Res Mol Biol</source>
        <year>1972</year>
        <volume>12</volume>
        <fpage>49</fpage>
        <lpage>85</lpage>
        <pub-id pub-id-type="doi">10.1016/S0079-6603(08)60659-5</pub-id>
        <?supplied-pmid 4557059?>
        <pub-id pub-id-type="pmid">4557059</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sprinzl</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vassilenko</surname>
            <given-names>KS</given-names>
          </name>
        </person-group>
        <article-title>Compilation of tRNA sequences and sequences of tRNA genes</article-title>
        <source>Nucleic Acids Res</source>
        <year>2005</year>
        <volume>33</volume>
        <issue>Database issue</issue>
        <fpage>D139</fpage>
        <lpage>D140</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gki012</pub-id>
        <?supplied-pmid 15608164?>
        <pub-id pub-id-type="pmid">15608164</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agris</surname>
            <given-names>PF</given-names>
          </name>
        </person-group>
        <article-title>The importance of being modified: roles of modified nucleosides and Mg2+ in RNA structure and function</article-title>
        <source>Prog Nucleic Acid Res Mol Biol</source>
        <year>1996</year>
        <volume>53</volume>
        <fpage>79</fpage>
        <lpage>129</lpage>
        <pub-id pub-id-type="doi">10.1016/S0079-6603(08)60143-9</pub-id>
        <?supplied-pmid 8650309?>
        <pub-id pub-id-type="pmid">8650309</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Takai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yokoyama</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Roles of 5-substituents of tRNA wobble uridines in the recognition of purine-ending codons</article-title>
        <source>Nucleic Acids Res</source>
        <year>2003</year>
        <volume>31</volume>
        <fpage>6383</fpage>
        <lpage>6391</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg839</pub-id>
        <?supplied-pmid 14602896?>
        <pub-id pub-id-type="pmid">14602896</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>F-Y</given-names>
          </name>
          <name>
            <surname>Tomizawa</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes</article-title>
        <source>Endocr J</source>
        <year>2011</year>
        <volume>58</volume>
        <fpage>819</fpage>
        <lpage>825</lpage>
        <pub-id pub-id-type="doi">10.1507/endocrj.EJ11-0099</pub-id>
        <?supplied-pmid 21908934?>
        <pub-id pub-id-type="pmid">21908934</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>F-Y</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kimura</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kaitsuka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fujimura</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Matsui</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Atta</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Michiue</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fontecave</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yamagata</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tomizawa</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice</article-title>
        <source>J Clin Invest</source>
        <year>2011</year>
        <volume>121</volume>
        <fpage>3598</fpage>
        <lpage>3608</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI58056</pub-id>
        <?supplied-pmid 21841312?>
        <pub-id pub-id-type="pmid">21841312</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>F-Y</given-names>
          </name>
          <name>
            <surname>Tomizawa</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Development of type 2 diabetes caused by a deficiency of a tRNAlys modification</article-title>
        <source>Islets</source>
        <year>2012</year>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tseng</surname>
            <given-names>WC</given-names>
          </name>
          <name>
            <surname>Medina</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Randerath</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Specific inhibition of transfer RNA methylation and modification in tissues of mice treated with 5-fluorouracil</article-title>
        <source>Cancer Res</source>
        <year>1978</year>
        <volume>38</volume>
        <fpage>1250</fpage>
        <lpage>1257</lpage>
        <?supplied-pmid 639058?>
        <pub-id pub-id-type="pmid">639058</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuchino</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Borek</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Grunberger</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mushinski</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Nishimura</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Changes of post-transcriptional modification of wye base in tumor-specific tRNAPhe</article-title>
        <source>Nucleic Acids Res</source>
        <year>1982</year>
        <volume>10</volume>
        <fpage>6421</fpage>
        <lpage>6432</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/10.20.6421</pub-id>
        <?supplied-pmid 6924749?>
        <pub-id pub-id-type="pmid">6924749</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aytaç</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Gündüz</surname>
            <given-names>U</given-names>
          </name>
        </person-group>
        <article-title>Q-modification of tRNAs in human brain tumors</article-title>
        <source>Cancer Biochem Biophys</source>
        <year>1994</year>
        <volume>14</volume>
        <fpage>93</fpage>
        <lpage>98</lpage>
        <?supplied-pmid 7889496?>
        <pub-id pub-id-type="pmid">7889496</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pathak</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jaiswal</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Vinayak</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Modulation in the activity of lactate dehydrogenase and level of c-Myc and c-Fos by modified base queuine in cancer</article-title>
        <source>Cancer Biol Ther</source>
        <year>2008</year>
        <volume>7</volume>
        <fpage>85</fpage>
        <lpage>91</lpage>
        <pub-id pub-id-type="doi">10.4161/cbt.7.1.5133</pub-id>
        <?supplied-pmid 18347422?>
        <pub-id pub-id-type="pmid">18347422</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yasukawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ueda</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ohta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Watanabe</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes</article-title>
        <source>J Biol Chem</source>
        <year>2000</year>
        <volume>275</volume>
        <fpage>4251</fpage>
        <lpage>4257</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.275.6.4251</pub-id>
        <?supplied-pmid 10660592?>
        <pub-id pub-id-type="pmid">10660592</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Isel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Marquet</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Keith</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ehresmann</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ehresmann</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription</article-title>
        <source>J Biol Chem</source>
        <year>1993</year>
        <volume>268</volume>
        <fpage>25269</fpage>
        <lpage>25272</lpage>
        <?supplied-pmid 7503978?>
        <pub-id pub-id-type="pmid">7503978</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Novoa</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Pavon-Eternod</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ribas de Pouplana</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>A role for tRNA modifications in genome structure and codon usage</article-title>
        <source>Cell</source>
        <year>2012</year>
        <volume>149</volume>
        <fpage>202</fpage>
        <lpage>213</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2012.01.050</pub-id>
        <?supplied-pmid 22464330?>
        <pub-id pub-id-type="pmid">22464330</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Czerwoniec</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dunin-Horkawicz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Purta</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kaminska</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Kasprzak</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Bujnicki</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Grosjean</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rother</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>MODOMICS: a database of RNA modification pathways. 2008 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2009</year>
        <volume>37</volume>
        <issue>Database issue</issue>
        <fpage>D118</fpage>
        <lpage>D121</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkn710</pub-id>
        <?supplied-pmid 18854352?>
        <pub-id pub-id-type="pmid">18854352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Machnicka</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Milanowska</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Osman Oglou</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Purta</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kurkowska</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Olchowik</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Januszewski</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kalinowski</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dunin-Horkawicz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rother</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Helm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bujnicki</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Grosjean</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>MODOMICS: a database of RNA modification pathways–2012 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>41</volume>
        <fpage>D262</fpage>
        <lpage>D267</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1007</pub-id>
        <?supplied-pmid 23118484?>
        <pub-id pub-id-type="pmid">23118484</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crooks</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Hon</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chandonia</surname>
            <given-names>J-M</given-names>
          </name>
          <name>
            <surname>Brenner</surname>
            <given-names>SE</given-names>
          </name>
        </person-group>
        <article-title>WebLogo: a sequence logo generator</article-title>
        <source>Genome Res</source>
        <year>2004</year>
        <volume>14</volume>
        <fpage>1188</fpage>
        <lpage>1190</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.849004</pub-id>
        <?supplied-pmid 15173120?>
        <pub-id pub-id-type="pmid">15173120</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ahmed</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GPS</given-names>
          </name>
        </person-group>
        <article-title>Designing of highly effective complementary and mismatch siRNAs for silencing a gene</article-title>
        <source>PLoS ONE</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e23443</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0023443</pub-id>
        <?supplied-pmid 21853133?>
        <pub-id pub-id-type="pmid">21853133</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hofacker</surname>
            <given-names>IL</given-names>
          </name>
        </person-group>
        <article-title>Vienna RNA secondary structure server</article-title>
        <source>Nucleic Acids Res</source>
        <year>2003</year>
        <volume>31</volume>
        <fpage>3429</fpage>
        <lpage>3431</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg599</pub-id>
        <?supplied-pmid 12824340?>
        <pub-id pub-id-type="pmid">12824340</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sato</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hamada</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Akutsu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Asai</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>IPknot: fast and accurate prediction of RNA secondary structures with pseudoknots using integer programming</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>i85</fpage>
        <lpage>i93</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr215</pub-id>
        <?supplied-pmid 21685106?>
        <pub-id pub-id-type="pmid">21685106</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lowe</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Eddy</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence</article-title>
        <source>Nucleic Acids Res</source>
        <year>1997</year>
        <volume>25</volume>
        <fpage>955</fpage>
        <lpage>964</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/25.5.0955</pub-id>
        <?supplied-pmid 9023104?>
        <pub-id pub-id-type="pmid">9023104</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Panwar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GP</given-names>
          </name>
        </person-group>
        <article-title>Prediction of vitamin interacting residues in a vitamin binding protein using evolutionary information</article-title>
        <source>BMC Bioinformatics</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>44</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-14-44</pub-id>
        <?supplied-pmid 23387468?>
        <pub-id pub-id-type="pmid">23387468</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cochella</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Brunelle</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Mutational analysis reveals two independent molecular requirements during transfer RNA selection on the ribosome</article-title>
        <source>Nat Struct Mol Biol</source>
        <year>2007</year>
        <volume>14</volume>
        <fpage>30</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1038/nsmb1183</pub-id>
        <?supplied-pmid 17159993?>
        <pub-id pub-id-type="pmid">17159993</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Panwar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GPS</given-names>
          </name>
        </person-group>
        <article-title>Prediction and classification of aminoacyl tRNA synthetases using PROSITE domains</article-title>
        <source>BMC Genomics</source>
        <year>2010</year>
        <volume>11</volume>
        <fpage>507</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-11-507</pub-id>
        <?supplied-pmid 20860794?>
        <pub-id pub-id-type="pmid">20860794</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Panwar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GPS</given-names>
          </name>
        </person-group>
        <article-title>Predicting sub-cellular localization of tRNA synthetases from their primary structures</article-title>
        <source>Amino Acids</source>
        <year>2012</year>
        <volume>42</volume>
        <fpage>1703</fpage>
        <lpage>1713</lpage>
        <pub-id pub-id-type="doi">10.1007/s00726-011-0872-8</pub-id>
        <?supplied-pmid 21400228?>
        <pub-id pub-id-type="pmid">21400228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vapnik</surname>
            <given-names>VN</given-names>
          </name>
        </person-group>
        <article-title>An overview of statistical learning theory</article-title>
        <source>IEEE Trans Neural Netw</source>
        <year>1999</year>
        <volume>10</volume>
        <fpage>988</fpage>
        <lpage>999</lpage>
        <pub-id pub-id-type="doi">10.1109/72.788640</pub-id>
        <?supplied-pmid 18252602?>
        <pub-id pub-id-type="pmid">18252602</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Joachims</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Making large-scale SVM learning practical</article-title>
        <source>Adv Kernel Methods Support Vector Learn</source>
        <year>1999</year>
        <fpage>169</fpage>
        <lpage>184</lpage>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>CT</given-names>
          </name>
        </person-group>
        <article-title>Prediction of protein structural classes</article-title>
        <source>Crit Rev Biochem Mol Biol</source>
        <year>1995</year>
        <volume>30</volume>
        <fpage>275</fpage>
        <lpage>349</lpage>
        <pub-id pub-id-type="doi">10.3109/10409239509083488</pub-id>
        <?supplied-pmid 7587280?>
        <pub-id pub-id-type="pmid">7587280</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Panwar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Arora</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GPS</given-names>
          </name>
        </person-group>
        <article-title>Prediction and classification of ncRNAs using structural information</article-title>
        <source>BMC Genomics</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>127</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-15-127</pub-id>
        <?supplied-pmid 24521294?>
        <pub-id pub-id-type="pmid">24521294</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Panwar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chauhan</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GP</given-names>
          </name>
        </person-group>
        <article-title>Analysis and prediction of cancerlectins using evolutionary and domain information</article-title>
        <source>BMC Res Notes</source>
        <year>2011</year>
        <volume>4</volume>
        <fpage>237</fpage>
        <pub-id pub-id-type="doi">10.1186/1756-0500-4-237</pub-id>
        <?supplied-pmid 21774797?>
        <pub-id pub-id-type="pmid">21774797</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Darty</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Denise</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ponty</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>VARNA: interactive drawing and editing of the RNA secondary structure</article-title>
        <source>Bioinformatics</source>
        <year>2009</year>
        <volume>25</volume>
        <fpage>1974</fpage>
        <lpage>1975</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp250</pub-id>
        <?supplied-pmid 19398448?>
        <pub-id pub-id-type="pmid">19398448</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
